See also this year's filing and all EDGAR filings for this company.
PDF Report 0001498382_2023_Kintara_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001498382, Kintara Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 13,258,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 90,000 |
| 3 | remainder_Assets | 2,600,000 |
| 4 | LiabilitiesCurrent | 3,990,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 163,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,509,000 |
| 9 | ResearchAndDevelopmentExpense | 15,173,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 21,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 15,948,000 |
| 1 | Liabilities | 4,153,000 |
| 2 | Expenses | 22,682,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 11,795,000 |
| 5 | NetIncome | -22,661,000 |
| 6 | ComprehensiveNetIncome | -22,661,000 |
| 7 | BaseVar | 21,402,000 |
| 8 | EconomicCapitalRatio | -0.236 |
Edgar->Model Mapping
Feature Distribution
Change over Time
